|
INCOME TAXES (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
|
Sep. 29, 2013
|
Mar. 31, 2013
|
Sep. 30, 2012
|
Sep. 29, 2013
|
Sep. 30, 2012
|
|
| Income tax disclosures | |||||
| Effective tax rate (as a percent) | 29.20% | 24.10% | 28.30% | 25.50% | |
| U.S. statutory rate, (as a percent) | 35.00% | ||||
| Net discrete income tax adjustment | $ 7 | $ (16) | |||
| Discrete tax expense (benefit) for prior year tax return true-up | 4 | (13) | |||
| Benefit related to release of prior year tax reserves | 1 | ||||
| Discrete tax charge for enactment of U.K. law changes | 4 | 3 | |||
| Net discrete income tax benefit (expense) attributable to 2012 research credit | 28 | ||||
| Net discrete income tax expense related to the write-off of a deferred tax asset deemed unrecoverable | 17 | ||||
| Benefit related to dividend distribution of accumulated foreign income earned in prior years | $ 6 | ||||
|
Estimate
|
|||||
| Income tax disclosures | |||||
| Effective tax rate (as a percent) | 28.50% | ||||
| X | ||||||||||
|
- Definition
Effective Income Tax Rate Reconciliation, Reconciling Items, Net, Amount No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The portion of the difference between total income tax expense or benefit as reported in the Income Statement and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to write-off of a deferred tax asset deemed unrecoverable. No definition available.
|
| X | ||||||||||
|
- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|